Equity Capital Markets

Company · CIK 1549595

Nurix Therapeutics, Inc.

CIK1549595 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressCA
ListedNRIX (Nasdaq)
First annual or quarterly report2020-10-14

Offerings

4 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-280117
ShelfEffective
 2024-06-112026-03-065
333-258448
ShelfEffective
 2021-08-042024-04-126
333-253783
Registered companyFinal prospectus
 2021-03-022021-03-053
333-239651
IPOFinal prospectus
 2020-07-022020-07-245

Filings

21
FiledFilingRegistrationAccession
2026-03-06424B5Shelf takedown 333-2801170001193125-26-096717
2025-10-22424B5Shelf takedown 333-2801170001193125-25-246969
2024-10-31424B5Shelf takedown 333-2801170001193125-24-248749
2024-07-11424B5Shelf takedown 333-2801170001193125-24-177748
2024-06-11S-3ASRShelf registered 333-2801170001193125-24-159103
2024-04-12424B5Shelf takedown 333-2584480001193125-24-094873
2024-04-11424B5Shelf takedown 333-2584480001193125-24-093198
2023-04-06EFFECTDeclared effective 333-2584489999999995-23-000840
2022-07-08424B5Shelf takedown 333-2584480001193125-22-190487
2022-07-08424B5Shelf takedown 333-2584480001193125-22-190482
2021-08-04S-3ASRShelf registered 333-2584480001193125-21-236301
2021-03-05424B4Final prospectus 333-2537830001193125-21-071458
2021-03-04EFFECTDeclared effective 333-2537839999999995-21-000848
2021-03-02S-1Registration filed 333-2537830001193125-21-065468
2021-02-22DRSDraft made public 377-042850000950123-21-003063
2020-07-24424B4Final prospectus 333-2396510001193125-20-198537
2020-07-23EFFECTDeclared effective 333-2396519999999995-20-001903
2020-07-23S-1/AAmendment 333-2396510001193125-20-197412
2020-07-20S-1/AAmendment 333-2396510001193125-20-195056
2020-07-02S-1Registration filed 333-2396510001193125-20-186809
2020-05-05DRSDraft made public 377-031530000950123-20-003951

All filings of this company · CSV